Item 5.07 Submission of Matters to a Vote of Security Holders.

On December 2, 2022, Nuo Therapeutics, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders. The following matters were considered and voted upon:



  1. To elect four directors to serve on the Company's Board of Directors, each to
     serve until the Company's next annual meeting of stockholders or until each
     successor is duly elected and qualified;



  2. To ratify the appointment of Marcum LLP as the Company's independent
     registered public accounting firm for the fiscal year ending December 31,
     2022;



  3. To approve, on an advisory basis, the compensation of the Company's named
     executive officers;



  4. To approve, on an advisory basis, the frequency of the advisory vote on
     executive compensation; and



  5. To ratify and approve the Company's 2016 Omnibus Incentive Compensation Plan,
     as amended.

The results of the vote were as follows:




1.   Election of Directors           For        Withheld    Broker Non-Votes
     David E. Jorden             26,699,444       3,323         996,251
     C. Eric Winzer              26,198,490      504,277        996,251
     Scott M. Pittman            26,199,444      503,323        996,251
     Paul D. Mintz               26,199,444      503,323        996,251

                                     For        Withheld        Abstain

2. To ratify the appointment


     of Marcum LLP as the
     Company's independent
     registered public           27,697,944       1,074            0
     accounting firm for the
     fiscal year ending
     December 31, 2022
                                     For        Withheld        Abstain

3. To approve, on an advisory


     basis, the compensation of  26,692,397       5,370          5,000
     the Company's named
     executive officers

                                  One Year      Two Years     Three Years     Abstain

4. To approve, on an advisory


     basis, the frequency of      2,389,764      37,874        23,767,794     507,335
     the advisory vote on
     executive compensation

                                     For        Withheld        Abstain

5. To ratify and approve the


     Company's 2016 Omnibus      26,188,825       7,988         505,954
     Incentive Compensation
     Plan, as amended

In light of the voting results on Proposal 4 the Board of Directors has determined that the Company will include an advisory vote on executive compensation in the Company's proxy materials every three years until the next required advisory vote on the frequency of future advisory votes on executive compensation, which will occur no later than the Company's 2028 Annual Meeting of Stockholders.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses